Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Non Operating Investment Income (2013 - 2025)

Updated

Ani Pharmaceuticals (ANIP) recorded Non Operating Investment Income of -$87,000 in Q4 2025.

Analysis

Ani Pharmaceuticals (ANIP) Non Operating Investment Income (2013 - 2025) Analysis & Trends

For FY2025, Ani Pharmaceuticals reported Non Operating Investment Income of -$382,000.

  • Across earlier years, Non Operating Investment Income came in at $5.35 million in FY2024.
  • The Q4 2025 figure is the highest quarterly Non Operating Investment Income since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Ani Pharmaceuticals 1.72 Bn 502.13 Mn 165.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -87,000.00
Sep 30, 2025 -295,000.00
Mar 31, 2024 5.35 Mn
Mar 31, 2013 1.00 Mn
API Access

Ani Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ANIP&period=max&api_key=YOUR_API_KEY